• Anti-Obesity Drugs Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Anti-Obesity Drugs Market, By Regions
• Anti-Obesity Drugs Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Anti-Obesity Drugs Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Anti-Obesity Drugs Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Anti-Obesity Drugs Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Global Anti-Obesity Drugs Market- Regional Dynamics
North America has witnessed significant growth in the recent past, owing to high level of
awareness among the people with obesity and the higher risks associated with the medical
condition, rise in healthcare expenditure, extensive and effective research and development
activities, involvement of government and non-government organizations in creating an
awareness and funding the research and higher number of adults with obesity in the region.
According to the World Health Organization, in 2016, over 1.9 billion adults who were aged 18
years and above were overweight and of these over 650 million were obese.
Global Anti-Obesity Drugs Market- Competitive Analysis
Manufactures are focused on development, manufacturing, and marketing of multisource and
branded pharmaceuticals. Key players in the global anti-obesity drug market are innovating new
and efficient anti-obesity drugs by adopting novel strategies to meet the demand from customers
with various types of obesity problems. For instance, in 2017, Boehringer Ingelheim GmbH and
Gubra announced collaboration and license agreement for the development of novel peptide